Study: Sarbanes-Oxley costs burden small firms
A Greater Boston Chamber of Commerce study released yesterday says the new Sarbanes-Oxley law imposes expensive compliance burdens on small companies, such as biotech and life science firms that are crucial to the future of the Massachusetts economy. (Full article: 433 words)
This article is available in our archives:
Globe Subscribers
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly





